US Bancorp’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $968K | Buy |
1,787
+209
| +13% | +$118K | ﹤0.01% | 1215 |
|
|
2026
Q1 | $936K | Buy |
1,578
+52
| +3% | +$25.9K | ﹤0.01% | 1183 |
|
|
2025
Q4 | $744K | Sell |
1,526
-647
| -30% | -$301K | ﹤0.01% | 1309 |
|
|
2025
Q3 | $911K | Sell |
2,173
-126
| -5% | -$42.4K | ﹤0.01% | 1182 |
|
|
2025
Q2 | $661K | Buy |
2,299
+328
| +17% | +$98K | ﹤0.01% | 1333 |
|
|
2025
Q1 | $608K | Buy |
1,971
+215
| +12% | +$73.7K | ﹤0.01% | 1361 |
|
|
2024
Q4 | $620K | Sell |
1,756
-23
| -1% | -$8.45K | ﹤0.01% | 1381 |
|
|
2024
Q3 | $638K | Sell |
1,779
-3
| -0.2% | -$1.01K | ﹤0.01% | 1366 |
|
|
2024
Q2 | $568K | Buy |
1,782
+125
| +8% | +$33.1K | ﹤0.01% | 1401 |
|
|
2024
Q1 | $381K | Sell |
1,657
-647
| -28% | -$146K | ﹤0.01% | 1662 |
|
|
2023
Q4 | $507K | Buy |
2,304
+446
| +24% | +$103K | ﹤0.01% | 1481 |
|
|
2023
Q3 | $420K | Sell |
1,858
-182
| -9% | -$41.9K | ﹤0.01% | 1460 |
|
|
2023
Q2 | $450K | Buy |
2,040
+135
| +7% | +$29.9K | ﹤0.01% | 1459 |
|
|
2023
Q1 | $427K | Buy |
1,905
+461
| +32% | +$114K | ﹤0.01% | 1487 |
|
|
2022
Q4 | $402K | Sell |
1,444
-629
| -30% | -$159K | ﹤0.01% | 1506 |
|
|
2022
Q3 | $434K | Buy |
2,073
+134
| +7% | +$30K | ﹤0.01% | 1461 |
|
|
2022
Q2 | $456K | Sell |
1,939
-181
| -9% | -$36.8K | ﹤0.01% | 1494 |
|
|
2022
Q1 | $380K | Sell |
2,120
-4
| -0.2% | -$762 | ﹤0.01% | 1659 |
|
|
2021
Q4 | $460K | Sell |
2,124
-217
| -9% | -$42.6K | ﹤0.01% | 1568 |
|
|
2021
Q3 | $433K | Buy |
2,341
+317
| +16% | +$62.4K | ﹤0.01% | 1593 |
|
|
2021
Q2 | $363K | Sell |
2,024
-115
| -5% | -$21.9K | ﹤0.01% | 1708 |
|
|
2021
Q1 | $358K | Sell |
2,139
-281
| -12% | -$46.9K | ﹤0.01% | 1666 |
|
|
2020
Q4 | $368K | Sell |
2,420
-2,788
| -54% | -$366K | ﹤0.01% | 1598 |
|
|
2020
Q3 | $526K | Sell |
5,208
-1,580
| -23% | -$173K | ﹤0.01% | 1306 |
|
|
2020
Q2 | $821K | Buy |
6,788
+1,488
| +28% | +$167K | ﹤0.01% | 1041 |
|
|
2020
Q1 | $503K | Buy |
5,300
+2,579
| +95% | +$245K | ﹤0.01% | 1192 |
|
|
2019
Q4 | $240K | Buy |
2,721
+742
| +37% | +$65.3K | ﹤0.01% | 1735 |
|
|
2019
Q3 | $158K | Buy |
1,979
+499
| +34% | +$40.2K | ﹤0.01% | 1925 |
|
|
2019
Q2 | $116K | Sell |
1,480
-280
| -16% | -$26.2K | ﹤0.01% | 2128 |
|
|
2019
Q1 | $207K | Sell |
1,760
-4,531
| -72% | -$528K | ﹤0.01% | 1798 |
|
|
2018
Q4 | $685K | Sell |
6,291
-217
| -3% | -$25.2K | ﹤0.01% | 1185 |
|
|
2018
Q3 | $833K | Buy |
6,508
+117
| +2% | +$14.5K | ﹤0.01% | 1205 |
|
|
2018
Q2 | $723K | Buy |
6,391
+863
| +16% | +$94.9K | ﹤0.01% | 1274 |
|
|
2018
Q1 | $621K | Buy |
5,528
+203
| +4% | +$25.8K | ﹤0.01% | 1344 |
|
|
2017
Q4 | $788K | Buy |
5,325
+1,195
| +29% | +$152K | ﹤0.01% | 1223 |
|
|
2017
Q3 | $484K | Sell |
4,130
-45
| -1% | -$5.75K | ﹤0.01% | 1428 |
|
|
2017
Q2 | $541K | Buy |
4,175
+128
| +3% | +$16K | ﹤0.01% | 1373 |
|
|
2017
Q1 | $548K | Buy |
4,047
+225
| +6% | +$34.1K | ﹤0.01% | 1363 |
|
|
2016
Q4 | $548K | Buy |
3,822
+1,802
| +89% | +$230K | ﹤0.01% | 1321 |
|
|
2016
Q3 | $239K | Sell |
2,020
-393
| -16% | -$47.2K | ﹤0.01% | 1678 |
|
|
2016
Q2 | $256K | Sell |
2,413
-626
| -21% | -$69.8K | ﹤0.01% | 1610 |
|
|
2016
Q1 | $340K | Buy |
3,039
+21
| +0.7% | +$2.66K | ﹤0.01% | 1456 |
|
|
2015
Q4 | $472K | Sell |
3,018
-158
| -5% | -$23K | ﹤0.01% | 1321 |
|
|
2015
Q3 | $417K | Buy |
3,176
+352
| +12% | +$56.5K | ﹤0.01% | 1376 |
|
|
2015
Q2 | $492K | Sell |
2,824
-1,695
| -38% | -$305K | ﹤0.01% | 1360 |
|
|
2015
Q1 | $780K | Sell |
4,519
-487
| -10% | -$74.2K | ﹤0.01% | 1141 |
|
|
2014
Q4 | $649K | Sell |
5,006
-1,283
| -20% | -$165K | ﹤0.01% | 1207 |
|
|
2014
Q3 | $809K | Sell |
6,289
-4,979
| -44% | -$513K | ﹤0.01% | 1067 |
|
|
2014
Q2 | $997K | Sell |
11,268
-11,250
| -50% | -$1.08M | ﹤0.01% | 1003 |
|
|
2014
Q1 | $2.12M | Sell |
22,518
-1,076
| -5% | -$110K | 0.01% | 675 |
|
|
2013
Q4 | $2.67M | Sell |
23,594
-3,367
| -12% | -$304K | 0.01% | 564 |
|
|
2013
Q3 | $2.13M | Buy |
26,961
+1,773
| +7% | +$130K | 0.01% | 610 |
|
|
2013
Q2 | $1.66M | Buy |
+25,188
| New | +$1.62M | 0.01% | 672 |
|
Other funds holding UTHR
ACA
JT
US Bancorp's UTHR Position: Q2 2026 in Review
US Bancorp increased its United Therapeutics (UTHR) stake by 13% in Q2 2026, buying an estimated $118K and bringing the position to 1,787 shares worth $968K. The position accounts for ﹤0.01% of the portfolio, ranked #1215.
US Bancorp first reported a position in UTHR in Q2 2013 and has held it in 53 quarters since. The position peaked at $2.67M in Q4 2013. 875 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.
- US Bancorp held 1,787 shares of United Therapeutics worth $968K as of Q2 2026.
- US Bancorp bought 209 United Therapeutics shares in Q2 2026, an estimated $118K.
- United Therapeutics made up ﹤0.01% of US Bancorp's portfolio in Q2 2026, its #1215 holding.
- US Bancorp first reported a position in United Therapeutics in Q2 2013 and has held it in 53 quarters since.
- US Bancorp's United Therapeutics position peaked at $2.67M in Q4 2013.
- 875 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.
Based on US Bancorp's 13F filing for Q2 2026, filed 12 Aug 2026.